We are live on ! Find out more
ONSIW

Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019
ONSIW

Delisted

ONSIW was delisted on the 3rd of December, 2018.

Back to rankings

0 hedge funds and large institutions have $0 invested in Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 in 2018 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 6 → 0 (-6)

100% less capital invested

Capital invested by funds: $20K → $0 (-$20K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 6

Holders
–
Holders Change
-6
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
-$9K
2
PA
Perceptive Advisors
New York
-$6K
3
ACA
Avoro Capital Advisors
New York
-$3K
4
MWNA
Marshall Wace North America
New York
-$1K
5
PC
PointState Capital
New York
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
– -$6K -420,875 Closed
CAM
2
Cormorant Asset Management
Massachusetts
– -$9K -416,666 Closed
ACA
3
Avoro Capital Advisors
New York
– -$3K -233,333 Closed
MWNA
4
Marshall Wace North America
New York
– -$1K -125,400 Closed
PC
5
PointState Capital
New York
– -$1K -100,000 Closed

ONSIW Hedge Fund Activity: Q4 2018 in Review

0 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 (ONSIW) for Q4 2018, worth a combined $0 — down 100% from $20K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of ONSIW and 0 opened new positions — a net loss of 6 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Cormorant Asset Management, exiting entirely with an estimated $9K sold.

  • 0 institutional investors held Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 (ONSIW) as of Q4 2018, down from 6 in Q3 2018.
  • Funds reported $0 of Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 stock for Q4 2018, down 100% quarter-over-quarter.
  • 0 funds opened new Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 positions in Q4 2018 and 6 closed out, a net change of -6 holders.
  • The largest Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 seller in Q4 2018 was Cormorant Asset Management, an estimated $9K sold.

Based on aggregated 13F filings for Q4 2018.